Pharmacology

Biliary Drugs

Antibiotics for biliary infections, cholestasis management, dissolution therapy & antispasmodics

Antibiotics for Biliary Infections

ScenarioPreferred Antibiotic(s)CoverageNotes
Acute cholecystitis (mild-moderate)Cefazolin (IV) or cephalexin (PO)Gram-negative enteric organisms (E. coli, Klebsiella)Start pre-op; short perioperative course; CEFAZOLIN is 1st line for surgical prophylaxis for cholecystectomy
Acute cholecystitis (severe/high-risk)Piperacillin-tazobactam (Zosyn) or ceftriaxone + metronidazoleBroad gram-negative + anaerobic coverageTreat until cholecystectomy or resolution; add metronidazole for anaerobic coverage in complicated cases
Ascending cholangitis (biliary emergency)Piperacillin-tazobactam OR ceftriaxone + metronidazole; carbapenems for severe/ICUGram-negative aerobic (E. coli, Klebsiella, Enterococcus) + anaerobesBlood cultures BEFORE antibiotics; urgent ERCP for biliary decompression is definitive; IV vancomycin if Enterococcus suspected
SBP prophylaxis (related to biliary disease)Norfloxacin 400mg daily or ciprofloxacin 500mg dailyGram-negative enteric organismsLong-term prophylaxis in cirrhotic patients with low-protein ascites or prior SBP episode
🎯 Boards PearlAntibiotic selection in biliary disease follows biliary flora: E. coli (most common), Klebsiella, Enterococcus, and anaerobes in complicated/elderly/post-procedural cases. Empiric coverage should always cover gram-negatives. Add anaerobic coverage (metronidazole) for complicated cholangitis, gangrenous cholecystitis, or elderly patients. Duration: usually 4–7 days (or until afebrile × 24–48h for uncomplicated cholecystitis).

Gallstone Dissolution Therapy

DrugIndicationMechanismCriteria & Response
Ursodeoxycholic acid (UDCA / ursodiol)Dissolution of small cholesterol gallstones in patients who are poor surgical candidates; prevention of gallstone formation during rapid weight lossHydrophilic bile acid → reduces cholesterol saturation of bile → gradual dissolution of cholesterol stonesRequires: cholesterol stones (not pigment), small (<5mm best; <20mm maximum), radiolucent on plain film, patent cystic duct, functioning GB. Duration: 6–24 months. Success: 40–60% dissolution for small stones; recurrence 50% at 5 years after stopping
🏥 When to Choose Medical vs. SurgicalElective laparoscopic cholecystectomy is definitive treatment for symptomatic gallstones and is preferred when patient is a surgical candidate. Ursodiol is reserved for: patients refusing surgery, very high surgical risk, or prevention of stone formation (e.g., on rapid weight loss program, total parenteral nutrition). Ursodiol does NOT dissolve pigment stones, calcium-containing stones, or stones >20mm.

Cholestasis & Pruritus Management

DrugMechanismUseKey Points
Cholestyramine (Questran)Bile acid sequestrant → binds bile acids in gut → reduces enterohepatic recirculation → decreases bile acid-mediated itchPruritus from cholestasis (PBC, cholestatic jaundice), hyperlipidemiaGive at least 1 hour before (or 4–6 hours after) other medications — impairs absorption of fat-soluble vitamins (A, D, E, K), digoxin, warfarin, thyroid hormones, statins. Side effects: constipation, bloating
Colesevelam (Welchol)Newer bile acid sequestrant; fewer drug interactionsPruritus, hyperlipidemia; also reduces glucose (adjunct for T2DM)Fewer drug interactions than cholestyramine; tablet form (better tolerability)
RifampinPXR nuclear receptor agonist → induces hydroxylation and sulfation of bile acids; also induces CYP enzymes → alters bile acid metabolismRefractory cholestatic pruritus (PBC, PSC)150–300mg BID; check LFTs — can cause hepatotoxicity; induces CYP3A4 → many drug interactions (reduces warfarin, OCP, statin effectiveness)
Naltrexone / NaloxoneOpioid receptor antagonist → blocks endogenous opioid-mediated itch signaling in cholestasisRefractory cholestatic pruritus; second or third-lineStart low dose (25mg/day naltrexone) to avoid opioid withdrawal reaction in opioid-naive patients
Sertraline (SSRI)Unknown mechanism in cholestatic pruritus; may modulate central itch perceptionRefractory cholestatic pruritus; adjunct therapy75–100mg/day; well-tolerated; can be combined with other agents

Antispasmodics & Motility Agents

DrugMechanismUseNotes
Hyoscine butylbromide (Buscopan)Anticholinergic (muscarinic M1/M3 antagonist) → smooth muscle relaxation → reduces biliary and GI spasmBiliary colic, IBS, GI spasmNot available in US (available in Canada/Europe); IV form used for biliary spasm perioperatively
Dicyclomine (Bentyl)Anticholinergic → smooth muscle relaxantGI/biliary spasm, IBSSide effects: dry mouth, urinary retention, tachycardia, blurred vision, constipation (anticholinergic syndrome)

Pain Management in Biliary Disease

DrugUseNotes
NSAIDs (ketorolac, diclofenac)Biliary colic — reduce prostaglandin-mediated gallbladder contraction and pain; may reduce risk of progression to cholecystitisKetorolac IV/IM for acute biliary colic in ER; effective as opioids for biliary colic in some studies; avoid in renal impairment
Opioids (morphine, hydromorphone, fentanyl)Moderate-severe biliary painMorphine may increase sphincter of Oddi pressure (theoretical concern, but clinical significance questioned); meperidine historically preferred but now discouraged due to seizure risk from normeperidine metabolite
Antacids / PPIsConcomitant GERD/dyspepsia often present with biliary disease; also preoperativePPIs do NOT treat biliary disease directly; address coexisting acid reflux symptoms
🎯 Boards PearlMorphine and sphincter of Oddi: classically taught that morphine causes sphincter of Oddi spasm → avoid in biliary colic; however, clinical evidence does not support avoiding morphine — use appropriate opioid for pain. Meperidine (Demerol) should be AVOIDED in biliary colic — the metabolite normeperidine is toxic (lowers seizure threshold), especially in renal impairment and elderly. Ketorolac is an excellent non-opioid option for acute biliary colic in the emergency setting.